Celanese Corporation

CE Basic Materials Chemicals

Celanese Corporation’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, down 7.05% from fiscal 2024.

Revenue
+8.69%
EPS
−37.4%
Free cash flow
−53.6%
Total debt
−7.22%

Quarter to June 2026, against a year earlier

47.77 1.53 −3.10%
Market cap
$5.4B
P/E
0.0×
Fwd P/E
11.3×
Dividend yield
0.25%
F-score
5/9
Altman Z
1.23
Beneish M
−3.03
Dividend safety
29/100

Insider Decisions last twelve months

Bought, $m 0.59
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy 2 — — — — — — — 3 — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.42%

Capital & Financial Ratios $m

Size
Market Cap 5,410.00
Revenue ttm 9,712.00
Net income ttm (1,154.00)
Free cash flow ttm 708.00
Net debt Q 10,643.00
Valuation
P/E 0.00
Forward P/E 11.30
Price / sales 0.54
Forward P/S Powerpack
Price / FCF 7.41
Price / book 1.14
Financial health
Current ratio Q 1.45
Debt / equity Q 2.62 (above 2: weak)
Interest coverage Q 1.48
Growth
Revenue growth Q +8.69% (above 0%: growing)
Operating income growth Q +19.48% (above 0%: growing)
EPS, this year +51.27% (at or above 15%: strong)
EPS, next year A +2.82%
Revenue, next year A +4.92%
EPS, past 5 yrs —
EPS, next 5 yrs A +21.47% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

P/S against its own 10 years 8.33%
10-year low 10-year high
P/B against its own 10 years 12.19%
10-year low 10-year high
EV/Sales against its own 10 years 8.74%
10-year low 10-year high
EV/FCF against its own 10 years 57.82%
10-year low 10-year high

Dividends

Yield
0.25%
Annual rate
0.12
Payout ratio
—
Growth, 2017–26
−25.7%/yr
  1. 1.74 ’17
  2. 2.08 ’18 +20%
  3. 2.40 ’19 +15%
  4. 2.48 ’20 +3%
  5. 2.72 ’21 +10%
  6. 2.74 ’22 +1%
  7. 2.80 ’23 +2%
  8. 2.80 ’24 +0%
  9. 0.12 ’25 −96%
  10. 0.12 ’26 +0%

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 1,805 962 1,263 1,364
Receivables 1,784 1,614 1,467 1,869
Inventory 2,357 2,284 2,220 2,305
Other 272 266 743 257
6,218 5,126 5,693 5,795
2023 2024 2025 Q'26
Payables 1,510 1,228 1,279 1,485
ST’ Debt 1,383 1,501 1,204 1,311
Other 1,154 1,157 1,124 1,106
4,072 3,890 3,683 4,006

Compound Annual Growth %

10y 5y 3y
Sales 5.34% 11.03% (0.45%)
Cash Flow 2.89% (3.12%) (14.27%)
Earnings 0.00% 0.00% 0.00%
Book Value 4.69% 2.80% (9.86%)

Earnings Trends EPS, adjusted, against the consensus

EPS $

Mar Jun Sep Dec Year
’26 0.40 1.13 — — —
’25 (0.22) 1.81 (12.39) 0.17 (10.64)
’24 1.10 1.41 1.06 (17.50) (13.93)
’23 0.83 2.01 8.69 6.37 17.92
’22 4.61 3.98 1.75 7.03 17.34
’21 2.82 4.77 4.56 4.79 16.86
’20 1.82 0.90 1.75 12.50 16.75
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 2,337 2,752 — — —
’25 2,389 2,532 2,419 2,204 9,544
’24 2,611 2,651 2,648 2,358 10,268
’23 2,853 2,795 2,723 2,555 10,926
’22 2,538 2,486 2,301 2,348 9,673
’21 1,798 2,198 2,266 2,275 8,537
’20 1,460 1,193 1,411 1,591 5,655
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 76 209 — — —
’25 37 410 447 252 1,146
’24 101 292 79 494 966
’23 (96) 762 403 830 1,899
’22 316 495 467 541 1,819
’21 116 427 630 584 1,757
’20 259 379 431 274 1,343
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 10 147 — — —
’25 (65) 317 383 168 803
’24 (36) 187 (9) 389 531
’23 (260) 617 272 702 1,331
’22 179 371 328 398 1,276
’21 24 317 528 421 1,290
’20 140 291 359 189 979
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 5,389 6,140 7,155 6,297 5,655 8,537 9,673 10,926 10,268 9,544 9,712 +6.6% 10,014 9,939 10,222 +2.3%
Gross margin, % 26.07 24.61 27.56 25.50 22.86 31.42 24.60 23.64 22.75 20.45 20.90 (5.6) pt
EBT 1,030 1,075 1,510 988 2,251 2,248 1,421 1,161 (1,019) (1,220) (1,123) n/m
EBT margin, % 19.11 17.51 21.10 15.69 39.81 26.33 14.69 10.63 (9.92) (12.78) (11.56) (31.9) pt
Net income 906 849 1,213 858 1,992 1,896 1,902 1,947 (1,534) (1,151) (1,154) n/m
Per share, $
Per share, $ Revenue 37.18 44.52 53.27 50.81 48.00 76.76 89.25 100.38 93.97 87.14 88.47 +9.9%
Earnings 6.21 6.11 8.99 6.88 16.85 16.99 17.48 18.01 (13.93) (10.64) (10.68) n/m
Cash flow 6.16 5.82 11.60 11.73 11.40 15.80 16.78 17.45 8.84 10.46 8.96 +6.1%
Capex (1.70) (1.94) (2.51) (2.99) (3.09) (4.20) (5.01) (5.22) (3.98) (3.13) (2.51) +7.0%
Free cash flow 4.46 3.89 9.09 8.75 8.31 11.60 11.77 12.23 4.86 7.33 6.45 +5.7%
Book value 20.84 23.92 25.16 23.38 33.06 40.79 56.33 69.38 50.91 40.83 41.79 +7.8%
Shares, m 145 138 134 124 118 111 108 109 109 110 110 (3.1%)
Valuation, ×
Valuation, × P/E 12.82 17.47 10.06 18.08 7.63 9.87 5.85 8.60 0.00 0.00 0.00 9.0
P/S 2.14 2.40 1.69 2.42 2.71 2.19 1.15 1.54 0.74 0.49 0.54 1.7
P/B 3.81 4.46 3.58 5.26 3.93 4.12 1.82 2.23 1.36 1.04 1.14 3.2
EV/Sales 2.57 2.89 2.12 2.96 3.10 2.59 2.51 2.63 1.87 1.67 1.64 2.5
EV/FCF 21.43 33.13 12.40 17.21 17.92 17.15 19.01 21.58 36.12 19.88 22.44 21.6
Cash, $m
Cash, $m Operating cash flow 893 803 1,558 1,454 1,343 1,757 1,819 1,899 966 1,146 984 +2.8%
Capex (246) (267) (337) (370) (364) (467) (543) (568) (435) (343) (276) +3.8%
Free cash flow 647 536 1,221 1,084 979 1,290 1,276 1,331 531 803 708 +2.4%
Balance, $m
Balance, $m Working capital 1,395 1,233 1,095 1,011 1,790 1,302 2,543 2,146 1,236 2,010 1,789 +4.1%
Net debt 2,340 3,033 3,061 3,402 2,235 3,431 13,171 11,879 11,617 11,335 10,643 +19.2%
Shareholders’ equity 3,021 3,299 3,379 2,898 3,895 4,537 6,105 7,552 5,563 4,472 4,588 +4.5%
Returns, %
Returns, % ROA 10.62 9.42 12.81 9.07 19.48 16.52 9.90 7.35 (6.24) (5.23) (5.18) (15.8) pt
ROIC 10.89 8.46 12.95 8.27 6.77 15.26 4.47 5.36 (2.62) (3.11) (2.84) (14.0) pt
ROE 30.77 26.68 36.15 27.15 58.44 44.83 35.59 28.45 (23.52) (23.22) (22.72) (54.0) pt
People
People Employees 7,293 7,592 7,684 7,714 7,658 8,529 13,263 12,410 12,163 11,434 — +5.1%
Revenue/emp, $m 0.74 0.81 0.93 0.82 0.74 1.00 0.73 0.88 0.84 0.83 — +1.4%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 25 Oct 2026

Celanese Corporation vs peers in Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
DOW Dow Inc. $25.1B — (loss-making) 17.7× +19.68% (above 0%: growing) +183.90% (above 0%: growing) +169.67% (above 0%: growing) 17.92% 7.29% Compare
CE Celanese Corporation $5.4B — (loss-making) 11.3× +8.69% (above 0%: growing) −37.36% (below 0%: shrinking) −53.63% (below 0%: shrinking) 22.46% 10.03%
OLN Olin Corporation $2.0B — (loss-making) — (loss-making) −0.93% (below 0%: shrinking) −1,100.00% (below 0%: shrinking) −111.64% (below 0%: shrinking) 9.77% 2.67% Compare
HUN Huntsman Corporation $1.7B — (loss-making) — (loss-making) +14.06% (above 0%: growing) n/m −266.67% (below 0%: shrinking) 14.73% 2.22% Compare
REX REX American Resources Corporation $1.3B 10.8× 13.7× +6.26% (above 0%: growing) +393.02% (above 0%: growing) +392.23% (above 0%: growing) 31.63% 22.36% Compare
GPRE Green Plains, Inc. $988.3M 7.9× 6.6× −19.28% (below 0%: shrinking) n/m +57.21% (above 0%: growing) 25.33% 15.21% Compare
LXU Lsb Industries Inc. $829.5M 23.0× 16.9× +11.10% (above 0%: growing) −325.00% (below 0%: shrinking) +9,653.02% (above 0%: growing) 6.82% (1.63%) Compare
WLKP Westlake Chemical Partners LP $749.3M 13.0× 14.2× −0.01% (below 0%: shrinking) −2.44% (below 0%: shrinking) +866.65% (above 0%: growing) 31.91% 29.39% Compare
TROX Tronox Holdings PLC $574.9M — (loss-making) — (loss-making) +18.74% (above 0%: growing) n/m +241.51% (above 0%: growing) 6.34% (2.42%) Compare
Median of peers $1.1B 11.9× 14.2× +8.68% −2.44% +205.59% 16.33% 4.98%

All 15 Chemicals stocks →

Pay and ownership Proxy statement filed 4 March 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 10.14m 7.09m 35.50
2024 12.80m (4.33m) 57.97
2023 12.97m 16.56m 127.61
2022 10.97m (8.92m) 81.97
2021 12.57m 41.53m 131.71

Ownership

Directors and executive officers, together less than 1%
Dodge & Cox 13.75%
BlackRock, Inc. 11.19%
The Vanguard Group, Inc. 10.72%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Celanese Corporation (CE) Latest News

2 Nov

26 Oct

16 Oct

Impact 3 · · Investing.com
Impact 3 · · Business Wire

9 Oct

Impact 3 · · Business Wire
Impact 3 · · Business Wire

26 Sep

21 Sep

11 Aug

Impact 3 · · The Motley Fool transcript

6 Aug

Impact 3 · · MarketBeat

11 May

Impact 4 · · Business Wire

9 May

Impact 3 · · MarketBeat
stockrow.com/CE · Data as of Oct 25, 2026 · For information only; not investment advice. · © 2026 stockrow.com